RESUMEN
Introduction: The US cigar market is diverse, yet until recently most research studies and tobacco surveillance systems have not reported behavioral and related outcomes by cigar type. Methods: The 2013-2014 Population Assessment of Tobacco and Health Study collected data separately for filtered cigars (FCs), cigarillos, and traditional cigars, which were further distinguished as premium or nonpremium. Descriptive statistics for adult established current smokers of each cigar type and cigarettes were calculated for demographic characteristics, tobacco use patterns, purchasing behaviors and reasons for use. Adjusted prevalence ratios (APRs) using a marginal predictions approach with logistic regression assessed correlates of dual cigar and cigarette smoking. Results: Age, sex, race/ethnicity, education level, and poverty status of smokers varied according to cigar type. Daily cigar smoking prevalence and number of cigars smoked per day were higher for FCs (37.3%; median: 1.6 cigars/day, respectively), than all other cigar types (6.7%-25.3%, all p < .01; 0.1-0.4 cigars/day, all p < .01, respectively); daily smoking and cigars per day were similar for nonpremium cigars and cigarillos (p = .11; p = .33, respectively). Cigarette smoking was twice as common among smokers of nonpremium cigars, cigarillos, and FCs (58.0%-66.0%) than among premium cigars (29.9%). Among current cigar smokers, FC smokers (APR = 1.23, 95% confidence interval [CI] = 1.09-1.39), other tobacco product users (APR = 1.27, 95% CI = 1.15-1.41), and those with a GED/high school diploma or less (APR = 1.20, 95% CI = 1.09-1.33) were more likely to also smoke cigarettes. Conclusion: User characteristics, cigar smoking patterns, and dual smoking with cigarettes varied by cigar type highlighting the importance of adequately describing the cigar type studied and, where appropriate, differentiating results by cigar type. Implications: Despite the diversity of the cigar market place, historically many research studies and tobacco surveillance systems have treated cigars as a single product type. This study describes similarities and differences in the user characteristics, tobacco use patterns, and purchasing behaviors of premium, nonpremium, cigarillo, and filtered cigar smokers. To enhance tobacco regulatory science, sufficient descriptions of the cigar type(s) studied and, where appropriate, differentiation of the particular cigar type(s) studied should be undertaken to improve the interpretation of study findings, understanding of cigar use patterns and related behaviors and future approaches to reducing cigar-attributable morbidity and mortality.
Asunto(s)
Fumar Puros/economía , Fumar Puros/epidemiología , Comportamiento del Consumidor/economía , Vigilancia de la Población , Productos de Tabaco/economía , Adolescente , Adulto , Fumar Puros/psicología , Estudios de Cohortes , Femenino , Humanos , Estudios Longitudinales , Masculino , Persona de Mediana Edad , National Institute on Drug Abuse (U.S.)/economía , National Institute on Drug Abuse (U.S.)/tendencias , Vigilancia de la Población/métodos , Fumadores/psicología , Productos de Tabaco/clasificación , Estados Unidos/epidemiología , United States Food and Drug Administration/economía , United States Food and Drug Administration/tendencias , Adulto JovenAsunto(s)
Investigación Biomédica , Cannabis/química , Marihuana Medicinal/provisión & distribución , National Institute on Drug Abuse (U.S.)/organización & administración , Cannabidiol/análisis , Cannabis/efectos adversos , Cannabis/crecimiento & desarrollo , Dronabinol/análisis , Humanos , Fumar Marihuana/legislación & jurisprudencia , Marihuana Medicinal/química , Marihuana Medicinal/economía , Marihuana Medicinal/uso terapéutico , National Institute on Drug Abuse (U.S.)/economía , Estados UnidosAsunto(s)
National Institute on Drug Abuse (U.S.) , Apoyo a la Investigación como Asunto , Historia del Siglo XX , Historia del Siglo XXI , National Institute on Drug Abuse (U.S.)/economía , National Institute on Drug Abuse (U.S.)/historia , National Institute on Drug Abuse (U.S.)/tendencias , Apoyo a la Investigación como Asunto/historia , Apoyo a la Investigación como Asunto/tendencias , Estados UnidosRESUMEN
BACKGROUND: The Consortium of Hospitals Advancing Research on Tobacco (CHART) is a network of six projects and a research coordinating unit funded by the National Heart, Lung, and Blood Institute, the National Cancer Institute, the National Institute on Drug Abuse, and the National Institutes of Health (NIH) Office of Behavioral and Social Science Research. The CHART projects will assess the effectiveness and cost-effectiveness of smoking cessation interventions initiated during hospitalization and continued post-discharge. METHODS/DESIGN: Along with a seventh project funded previously under the NIH Challenge grants, the CHART projects will assess smoking cessation strategies delivered to approximately 10,000 hospitalized smokers across a geographically diverse group of nearly 20 private, public, academic, and community hospitals. The CHART research coordinating unit at Kaiser Permanente Center for Health Research provides organizational and data coordination support, facilitating the development of common measures for combining data from multiple CHART projects. DISCUSSION: The targeted enrollment in CHART, if achieved, will represent the largest, most diverse pooled dataset of hospitalized smokers receiving smoking cessation assistance, and is designed to contribute to the dissemination and implementation of smoking cessation interventions provided by hospital systems.